维普期刊资源整合服务平台（V6.5）

22篇 您的检索式：作者名="Yonal O"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Noninvasive assessment of liver fibrosis with the aspartate transaminase to platelet ratio index (APRI) : Usefulness in patients with chronic liver disease: APRI in chronic liver disease 显示文摘	Yilmaz Y Yonal O Kurt R	2011	Hepat Mon2011，11，2：	1
2	Serum progranulin as an independent marker of liver fibrosis in patients with biopsy-proven nonalcoholic fatty liver disease显示文摘	Yilmaz Y Eren F Yonal O	2011	Dis Markers2011，31，4：	1
3	Serum levels of omen-tin,chemerin and adipsin in patients with biopsy-proven nonalcoholic fatty liver disease显示文摘	Yilmaz Y Yonal O Kurt R	2011	Scand J Gastroen-terol2011，46，1：	1
4	Dipeptidyl peptidase IV inhibi- tors: therapeutic potential in nonalcoholic fatty liver disease 显示文摘	Yilmaz Y Atug O Yonal O etal	2009	Med Sci Monit2009，15，4：	1
5	Decreased prohepcidin levels in patients with HBV-related liver disease:relation with ferritin levels显示文摘	Yonal O Akyuz F Demir K	2010	Dig Dis Sci2010，55，12：	1
6	The impact of early percutaneous endoscopic gastrostomy placement on treatment completeness and nutritional status in locally advanced head and neck cancer patients receiving che moradiot he rapy显示文摘	Atasoy BM Yonal O Demirel B	2012	Eur Arch Otorhinolaryngol2012，269，1：	1
7	Dipeptidyl peptidase IV in- hibitors :therapeutic potential in nonalcoholic fatty liver disease 显示文摘	Yilmaz Y Atug O Yonal O	2009	Med Sci Monit2009，15，4：	1
8	Increased serum FGF21 levels in patients with nonalcoholic fatty liver disease显示文摘	Yilmaz Y Eren F Yonal O	2010	Eur J Clin Invest2010，40，10：	1
9	Dipeptidyl peptidase IV inhibitors: therapeutic potential in nonalcoholic fattyliver dis- ease显示文摘	YILMAZ Y ATUG O YONAL O	2009	Med SciMonit2009，15，4：	1
10	Dipeptidyl peptidase Ⅳ inhibitors: therapeutic potential in nonalcoholic fatty liver disease 显示文摘	Yilmaz Y Atug O Yonal O	2009	Med Sci Monit2009，15，4：	1
11	Serum levels of omentin, chemerin and adipsin in patients with biopsy-proven nonalcoholic fatty liver disease 显示文摘	Yilmaz Y Yonal O Kurt R	2011	Scand J Gastroenterol2011，46，1：	1
12	Microalbuminuria in nondiabetic patients with nonalcoholic fatty liver disease:association with liver fibrosis显示文摘	Yilmaz Y Alahdab YO Yonal O		0，，09：	1
13	Serum progranulin as an independent market of liver fibrosis in patients with biopsy-proven nonalcoholic fatty liver disease显示文摘	Yilmas Y Eren F Yonal O	2011	Dis Markers2011，31，4：	1
14	Serum fetuin A/2HS-glycoprotein levels in patients with non-alcoholic fatty liver disease: relation with liver fibrosis显示文摘	Yilmaz Y Yonal O Kurt R	2010	Ann Clin Biochem2010，47，6：	1
15	Microalbuminuria in nondiabetic patients withnonalcoholic fatty liver disease : association withliver fibrosis 显示文摘	YILMAZ Y ALAHDAB Y O YONAL O	2010	Metabolism2010，59，：	1
16	Serum levels of omentin, chemerin and adipsin in patients with biopsy-proven nonalcoholic fatty liver disease显示文摘	Yilmaz Y Yonal O Kurt R	2010	Scand J Gastroenterol2010，46，1：	1
17	Dipeptidyl peptidase IV inhibi- tors:therapeutic potential in nonalcoholic fattyliver disease 显示文摘	Yilmaz Y Atug 0 Yonal O	2009	Med Sci Monit2009，15，4：	1
18	Increased serum FGF21 levels in patients w ith non-alcoholic fatty liver disease显示文摘	Yilmaz Y Eren F Yonal O	2010	Eur J Clin Invest2010，40，：	1
19	Coronary flow re-serve is impaired in patients with nona- lcoholic fatty liver disease:association with liver fibrosis显示文摘	Yilmaz Y Kurt R Yonal O	2010	Atherosclerosis2010，211，1：	1
20	Dipeptidyl peptidaseⅣinhibitors:therapeutic potential in nonalcoholic fatty liver disease显示文摘	Yilmaz Y Atug O Yonal O	2009	Med Sci Monit2009，15，4：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示